Detalhe da pesquisa
1.
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine.
Anesthesiology
; 129(5): 970-988, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30212413
2.
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat.
Anesthesiology
; 125(4): 732-743, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27466033
3.
Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.
Anesthesiology
; 113(1): 58-73, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20526187
4.
Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.
J Med Chem
; 46(12): 2502-15, 2003 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-12773054
5.
Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
Can J Anaesth
; 50(9): 879-85, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14617582
6.
Clinical pharmacology of GW280430A in humans.
Anesthesiology
; 100(4): 768-73, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15087609
7.
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.
Anesthesiology
; 100(4): 835-45, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15087618
8.
GW280430A: pharmacodynamics and potential adverse effects.
Anesthesiology
; 102(4): 861-2; author reply 862-3, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15791118